Publications by authors named "Kay Noel"

Claim this Profile
I
Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models.
Lucile Astorgues-Xerri, Ramiro Vázquez, Elodie Odore, Keyvan Rezai, Carmen Kahatt, Kay Noel

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.
Brent R Stockwell, José Pedro Friedmann Angeli, Hülya Bayir, Ashley I Bush, Marcus Conrad, Kay Noel

Cell· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.
Deborah A Bilder, J Kay Noel, Erin R Baker, William Irish, Yinpu Chen

Dev Neuropsychol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations.
Maria E Riveiro, Lucile Astorgues-Xerri, Ramiro Vazquez, Roberta Frapolli, Ivo Kwee, Kay Noel

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
Caroline Berenguer-Daizé, Lucile Astorgues-Xerri, Elodie Odore, Mylène Cayol, Esteban Cvitkovic, Kay Noel

Int J Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib.
Massimo Zucchetti, Katiuscia Bonezzi, Roberta Frapolli, Federica Sala, Patrizia Borsotti, Kay Noel

Cancer Chemother Pharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review to establish the safety profiles for direct and indirect inhibitors of p38 Mitogen-activated protein kinases for treatment of cancer. A systematic review of the literature.
J Kay Noel, Sheila Crean, Janet E Claflin, Gayatri Ranganathan, Heather Linz

Med Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis.
Susan E Waisbren, Kay Noel, Kyle Fahrbach, Catherine Cella, Diana Frame

Mol Genet Metab· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally invasive colorectal resection outcomes: short-term comparison with open procedures.
J Kay Noel, Kyle Fahrbach, Rhonda Estok, Catherine Cella, Diana Frame

J Am Coll Surg· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis